DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Netherlands
  • /
  • Materials
Author Program NEWCreate Narrative
DSFIR logo

DSM-Firmenich AG Stock Price

ENXTAM:DSFIR Community·€22.0b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 67 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

DSFIR Share Price Performance

€88.92
9.26 (11.62%)
​
€79.37
Fair Value
€88.92
9.26 (11.62%)
12.0% overvalued intrinsic discount
€79.37
Fair Value
Price €88.92
AnalystConsensusTarget €79.37
AnalystHighTarget €106.00
AnalystLowTarget €68.68
Wed, 24 Jun 26
Fair Value€79.37
Share Pricen/a

DSFIR Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value €79.37 12.0% overvalued intrinsic discount

DSFIR: Resilient Consumer Health Demand Will Drive Performance Amid Pricing Pressure

0users have liked this narrative
0users have commented on this narrative
30users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value €106 16.1% undervalued intrinsic discount

Sustainability And Precision Nutrition Will Fuel Global Market Expansion

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value €68.68 29.5% overvalued intrinsic discount

Regulatory And Merger Challenges Will Constrain Benefits But Spark Growth

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
DSFIR logo
DSM-Firmenich
12.0% overvalued intrinsic discount

DSFIR: Resilient Consumer Health Demand Will Drive Performance Amid Pricing Pressure

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 24 Jun
Read Narrative
DSFIR logo
DSM-Firmenich
29.5% overvalued intrinsic discount

Regulatory And Merger Challenges Will Constrain Benefits But Spark Growth

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 3 Sep
Read Narrative
DSFIR logo
DSM-Firmenich
16.1% undervalued intrinsic discount

Sustainability And Precision Nutrition Will Fuel Global Market Expansion

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 20 Aug
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
DSFIR logo

DSFIR: Sector Downturn And Cost Inflation Will Pressure Future Share Repurchase Effectiveness

Fair Value: €68.68 29.5% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
DSFIR logo

DSFIR: Share Buyback And Dual Listing Will Support Bullish Re Rating

Fair Value: €106 16.1% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
DSFIR logo

DSFIR: Share Buyback And New Listing Plan Will Shape Future Re Rating

Fair Value: €79.37 12.0% overvalued intrinsic discount
30 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Excellent balance sheet with moderate growth potential.

2 Risks
2 Rewards
View Full Analysis

DSM-Firmenich AG Key Details

€9.1b

Revenue

€5.5b

Cost of Revenue

€3.5b

Gross Profit

€3.2b

Other Expenses

€324.0m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Feb 18, 2027
1.31
39.18%
3.58%
37.6%
View Full Analysis

About DSFIR

Founded
1902
Employees
20786
CEO
Dimitri de Vreeze
WebsiteView website
www.dsm-firmenich.com

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through Perfumery & Beauty; Taste, Texture & Health; and Health, Nutrition & Care segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, hydrocolloids, cultures, natural colorants, nutritional ingredients, and plant-based proteins. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, biomedical materials, and nutrition improvement markets. This segment also offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, postbiotics, probiotics and prebiotics, and active pharmaceutical ingredients; biomedical solutions; and premix, market-ready, and personalized nutrition solutions, as well as expert services in regulatory affairs and nutrition. DSM-Firmenich AG was founded in 1902 and is based in Kaiseraugst, Switzerland.

Recent DSFIR News & Updates

User avatar
Narrative Update • Sep 03

DSFIR: Sector Downturn And Cost Inflation Will Pressure Future Share Repurchase Effectiveness

The analyst price target for DSM-Firmenich increases from €67.00 to €68.68, reflecting updated assumptions on fair value and profitability that align with a recent cluster of higher Street targets across a range of ratings. Analyst Commentary Recent Street research on DSM-Firmenich shows a wide spread in views on the stock, with price targets ranging from €65 to €106 and ratings spanning Sell to Buy.
User avatar
Narrative Update • Aug 20

DSFIR: Share Buyback And Dual Listing Will Support Bullish Re Rating

DSM-Firmenich's analyst price target has been revised to €106 from €115.35. Analysts cite updated assumptions around revenue growth, profit margins and a lower future P/E multiple.

Recent updates

No updates

DSM-Firmenich AG Competitors

MT logo

ArcelorMittal

Symbol: ENXTAM:MT
Market cap: €48.5b
AKZA logo

Akzo Nobel

Symbol: ENXTAM:AKZA
Market cap: €10.0b
APAM logo

Aperam

Symbol: ENXTAM:APAM
Market cap: €3.3b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide